-
Mashup Score: 84
Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a sys
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 84
Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a sys
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
2 most important tables you'll need for VTE prophylaxis and treatment with DOACs in patients with cancer. https://t.co/pfff2bEiT0 @ecancer https://t.co/oaYSxm2mIP
-
-
Mashup Score: 77
Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a sys
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
2 most important tables you'll need for VTE prophylaxis and treatment with DOACs in patients with cancer. https://t.co/pfff2bEiT0 @ecancer https://t.co/oaYSxm2mIP
-
-
Mashup Score: 33Defining geriatric oncology - ecancer - 4 month(s) ago
Dr Bishal Gyawali explores the definition of geriatric oncology and how it can change. He explains that the ‘cut-off’ age for defining geriatric
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
New video in @ecancer ! In this new video, I discuss the challenges of defining older adults based on an age cut-off in the context of #geriatriconcology. https://t.co/yGmkiz3Atw
-
-
Mashup Score: 18Revolving door between the regulators and industry - ecancer - 5 month(s) ago
Dr Bishal Gyawali discusses with ecancer an article from BMJ about the revolving door between the FDA and the pharmaceutical industry. He elaborates on the p
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
Revolving door between the regulators and the industry, and why we should be concerned. My new video @ecancer : https://t.co/3UVMrvsYVT
-
-
Mashup Score: 1
Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a sys
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
@Eddie_Cliff @RPTHjournal @FralickMike @thrombosisday We didn’t have such colourful infographics but still 😀 https://t.co/o6fMcElkEc
-
-
Mashup Score: 250
Eduardo Cazap1,2 and Enrique Soto Pérez de Celis1,3,4 1ecancer, 13 King Square Avenue, Bristol, BS2 8HU, UK 2Slacom, Cordoba 2415, Buenos
Source: ecancer.orgCategories: General Medicine News, Oncologists2Tweet-
I'm very proud to announce that I have been named Editor-in-Chief of @ecancer's journal Ecancermedicalscience. Looking forward to working together to help enhance the voices of cancer researchers from developing regions #globonc #globaloncology https://t.co/CXR44Ioliq
-
-
Mashup Score: 42ASCO 2024: Highlights and analysis - ecancer - 6 month(s) ago
Associate Professor Bishal Gyawali talks to ecancer reporter Saira Ahmed about several presentations from ASCO 2024; on topics such as patient-centric trials, l
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
My annual tradition of doing the @ASCO highlights video with @ecancer continues! An unbiased critical summary of the major takeaways from #ASCO24, straight from Chicago. Here you go: https://t.co/uG3vVusqoN
-
-
Mashup Score: 4ASCO 2024: Lung cancer roundup - ecancer - 6 month(s) ago
Dr Luis Raez gives his thoughts on key studies in lung cancer from ASCO 2024. He covers the following studies: 00:24 CROWN: 5 year progres
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
RT @LuisRaezMD: ASCO 2024: Lung cancer roundup thanks to @ecancer for the interview https://t.co/LVXaCebJSX Comenting here CROWN, ADRIATIC…
-
-
Mashup Score: 41ASCO 2024: Highlights and analysis - ecancer - 6 month(s) ago
Associate Professor Bishal Gyawali talks to ecancer reporter Saira Ahmed about several presentations from ASCO 2024; on topics such as patient-centric trials, l
Source: ecancer.orgCategories: General Medicine News, Hem/OncsTweet-
My annual tradition of doing the @ASCO highlights video with @ecancer continues! An unbiased critical summary of the major takeaways from #ASCO24, straight from Chicago. Here you go: https://t.co/uG3vVusqoN
-
2 most important tables you'll need for VTE prophylaxis and treatment with DOACs in patients with cancer. https://t.co/pfff2bEiT0 @ecancer https://t.co/oaYSxm2mIP